Ibrexafungerp | MedChemExpress (MCE)
Ibrexafungerp (MK 3118) is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp can be used for research of Candida and Aspergillus infections[1].
Trivial name | Ibrexafungerp |
Catalog Number | HY-107126 |
Alternative Name(s) | MK 3118; SCY-078 |
Research Area | Infection |
CAS# | 1207753-03-4 |
Purity | ≥98.0% |
SMILES | C[C@@]12[C@@](CC3)([H])[C@@](C[C@](N4C(C5=CC=NC=C5)=NC=N4)([H])[C@@H]1OC[C@](C)(N)C(C)(C)C)(COC2)C([C@@]3([H])[C@]6(CC[C@]7(C)[C@H](C)C(C)C)C)=CC[C@]6([C@@H]7C(O)=O)C |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/ibrexafungerp.html |